Clinical Trial Update: The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH [NA]

View source ↗

Summary

Update on the Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH); the trial status is completed and involves patients with diabetes and chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Chronic Kidney Disease
• Diabetes Mellitus

Snippet

Sponsor: University of Alberta | Conditions: Diabetes, Chronic Kidney Disease | NA | Status: COMPLETED